<DOC>
	<DOC>NCT00855959</DOC>
	<brief_summary>The primary objective of the study is to show similarity of efficacy on Pulmicort Respules 1.0 mg/day or 2.0 mg/day for 6 weeks in the treatment period and the corresponding doses of Pulmicort Turbuhaler 400 μg/day or 800 μg/day for 4 weeks in the observation period in Japanese adult asthmatic patients with age of 16 years or older.</brief_summary>
	<brief_title>Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Budesonide</mesh_term>
	<criteria>Provision of informed consent prior to any study specific procedures. A minimum of 6 months documented history of asthma according to the JGL 2006 definition Asthma patients under prescribed treatment with ICS at least 3 months before Visit 2. Current or previous tobacco smokers with a history of &gt;= 10 packyears Use of βblockers including eye drops Clinically significant respiratory infection affecting the asthma, as judged by the investigator(s) within 4 weeks prior to visit 2 Intake of oral, rectal or parenteral GCS within 4 weeks prior to Visit 2</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Pulmicort Respules</keyword>
</DOC>